Wolverine Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Wolverine Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,000	Closed	-$7.57M	–	2133
2020 Q4	$7.57M	Hold	50,000	–	–	0.06%	208
2020 Q3	$6.77M	Hold	50,000	–	–	0.06%	180
2020 Q2	$6.83M	Hold	50,000	–	–	0.07%	185
2020 Q1	$5.39M	Hold	50,000	–	–	0.08%	194
2019 Q4	$6.03M	Hold	50,000	–	–	0.07%	218
2019 Q3	$4.97M	Hold	50,000	–	–	0.06%	223
2019 Q2	$5.46M	Buy	+50,000	New	+$5.32M	0.07%	221

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wolverine Asset Management's IBB Position: Q2 2021 in Review

Wolverine Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 13,996 shares — an estimated $2.11M sold.

Wolverine Asset Management first reported a position in IBB in Q2 2013 and held it in 3 quarters. The position peaked at $2.11M in Q1 2021. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Wolverine Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 13,996 iShares Biotechnology ETF shares in Q2 2021, an estimated $2.11M.
Wolverine Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 3 quarters.
Wolverine Asset Management's iShares Biotechnology ETF position peaked at $2.11M in Q1 2021.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.